{"result": "Here is a comprehensive summary of the data:\n\nThe \"KATERINE TRIAL\" is a clinical trial that evaluates the effectiveness of adjuvant therapy in patients with HER2+ breast cancer, specifically in cases of inflammatory breast cancer (IBC) without a pathologic complete response (pCR). The trial investigates the use of adjuvant T-DM1, a type of targeted therapy, in these patients. The trial's findings recommend the use of adjuvant T-DM1 in HER2+ IBC cases without a pCR.\n\nNote: I resolved the contradictions by combining the information from the three descriptions, ensuring that the summary is coherent and accurate.", "input": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we the have full context.\n\n#######\n-Data-\nEntities: \"\\\"KATERINE TRIAL\\\"\"\nDescription List: [\"\\\"KATERINE trial is a clinical trial evaluating adjuvant therapy in patients with HER2+ breast cancer.\\\"\", \"\\\"KATERINE trial is a clinical trial investigating the use of adjuvant T-DM1 in HER2+ IBC cases without a pCR.\\\"\", \"\\\"KATERINE trial is a clinical trial that recommended adjuvant T-DM1 in HER2+ IBC cases without a pCR.\\\"\"]\n#######\nOutput:\n", "parameters": {"model": "llama3-8b-8192", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 500, "n": null}}